XJAN vs. XAPR
XJAN (FT Vest U.S. Equity Enhance & Moderate Buffer ETF - January) and XAPR (FT Cboe Vest U.S. Equity Enhance & Moderate Buffer ETF - April) are both Options Trading funds from FT Vest. Both are actively managed. Over the past year, XJAN returned 11.88% vs 8.79% for XAPR. A 0.80 correlation means they provide meaningful diversification when combined. Both charge a 0.85% expense ratio.
Performance
XJAN vs. XAPR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XJAN achieves a 4.03% return, which is significantly higher than XAPR's 3.39% return.
XJAN
- 1D
- -0.12%
- 1M
- 1.64%
- YTD
- 4.03%
- 6M
- 4.80%
- 1Y
- 11.88%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
XAPR
- 1D
- -0.16%
- 1M
- 1.66%
- YTD
- 3.39%
- 6M
- 4.05%
- 1Y
- 8.79%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
XJAN vs. XAPR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
XJAN FT Vest U.S. Equity Enhance & Moderate Buffer ETF - January | 4.03% | 9.14% | 7.52% |
XAPR FT Cboe Vest U.S. Equity Enhance & Moderate Buffer ETF - April | 3.39% | 12.57% | 8.25% |
Correlation
The correlation between XJAN and XAPR is 0.78, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.78 |
Correlation (All Time) Calculated using the full available price history since Apr 23, 2024 | 0.80 |
The correlation between XJAN and XAPR has been stable across timeframes, ranging from 0.78 to 0.80 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XJAN vs. XAPR — Risk / Return Rank
XJAN
XAPR
XJAN vs. XAPR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for FT Vest U.S. Equity Enhance & Moderate Buffer ETF - January (XJAN) and FT Cboe Vest U.S. Equity Enhance & Moderate Buffer ETF - April (XAPR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| XJAN | XAPR | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.52 | 4.31 | -1.79 |
Sortino ratioReturn per unit of downside risk | 3.77 | 7.30 | -3.54 |
Omega ratioGain probability vs. loss probability | 1.58 | 2.06 | -0.48 |
Calmar ratioReturn relative to maximum drawdown | 2.95 | 13.37 | -10.43 |
Martin ratioReturn relative to average drawdown | 16.89 | 70.60 | -53.71 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| XJAN | XAPR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.52 | 4.31 | -1.79 |
Sharpe Ratio (All Time)Calculated using the full available price history | 1.32 | 1.88 | -0.56 |
Drawdowns
XJAN vs. XAPR - Drawdown Comparison
The maximum XJAN drawdown since its inception was -10.04%, which is greater than XAPR's maximum drawdown of -6.18%. Use the drawdown chart below to compare losses from any high point for XJAN and XAPR.
Loading charts...
Drawdown Indicators
| XJAN | XAPR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -10.04% | -6.18% | -3.86% |
Max Drawdown (1Y)Largest decline over 1 year | -4.05% | -0.66% | -3.39% |
Current DrawdownCurrent decline from peak | -0.13% | -0.16% | +0.03% |
Average DrawdownAverage peak-to-trough decline | -0.58% | -0.18% | -0.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 0.70% | 0.12% | +0.58% |
Volatility
XJAN vs. XAPR - Volatility Comparison
The current volatility for FT Vest U.S. Equity Enhance & Moderate Buffer ETF - January (XJAN) is 0.65%, while FT Cboe Vest U.S. Equity Enhance & Moderate Buffer ETF - April (XAPR) has a volatility of 0.75%. This indicates that XJAN experiences smaller price fluctuations and is considered to be less risky than XAPR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XJAN | XAPR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.65% | 0.75% | -0.10% |
Volatility (6M)Calculated over the trailing 6-month period | 4.08% | 1.31% | +2.77% |
Volatility (1Y)Calculated over the trailing 1-year period | 4.74% | 2.05% | +2.69% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 7.22% | 6.18% | +1.04% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 7.22% | 6.18% | +1.04% |
XJAN vs. XAPR - Expense Ratio Comparison
Both XJAN and XAPR have an expense ratio of 0.85%.
Dividends
XJAN vs. XAPR - Dividend Comparison
Neither XJAN nor XAPR has paid dividends to shareholders.
Frequently Asked Questions
XJAN and XAPR have a correlation of 0.78, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XAPR has higher volatility (0.75%) compared to XJAN (0.65%). In terms of maximum drawdown, XJAN dropped -10.04% vs XAPR's -6.18%.
On 1-year performance, XJAN leads with 11.88% vs 8.79% for XAPR. Both ETFs have the same 0.85% expense ratio. On volatility, XJAN has been the lower-risk option at 0.65%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, XJAN has performed better with a 11.88% return vs 8.79%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XJAN and XAPR have the same expense ratio: 0.85% per year.
XJAN and XAPR have nearly identical dividend yields, around 0.00%.
XAPR currently has the higher Sharpe Ratio (4.31 vs 2.52), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XJAN and XAPR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer